Research identifies Europe's regulatory problems

25 September 2014 - Deborah Wilkes

Archived

The European Union's regulatory system for medicines could be used in a "more efficient and effective manner", according to research carried out by Escher, which identifies problems with pharmacovigilance as well as the mutual recognition and decentralised authorisation procedures.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: